The AdvanTIG-202 study represents an open-label phase 2 clinical trial...
Medical oncologist Prof Christine Gennigens from CHU de Liège and...
Prof Ramez Eskander, a gynaecological oncologist at the University of...
Laure-Anne Teuwen, a medical oncologist at the University Hospital of Antwerp,...
Prof Christine Gennigens, a medical oncologist at CHU de Liège, and Prof Els...
Professor Christine Gennigens, a distinguished medical oncologist at CHU de...
Prof Christine Gennigens, a medical oncologist at CHU de Liège, conducted an...
Prof Dr Els Van Nieuwenhuysen presents the latest findings from the proffered...
Prof Jean-François Baurain, medical oncologist at Cliniques universitaires...
Prof Els Van Nieuwenhuysen discussed the initial efficacy and safety results...